 | • レポートコード：MRC2-11QY04063 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は眼科用医薬品・装置のグローバル市場について調査・分析したレポートです。種類別（装置、医薬品）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別眼科用医薬品・装置の競争状況、市場シェア ・世界の眼科用医薬品・装置市場：種類別市場規模 2015年-2020年（装置、医薬品） ・世界の眼科用医薬品・装置市場：種類別市場規模予測 2021年-2026年（装置、医薬品） ・世界の眼科用医薬品・装置市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の眼科用医薬品・装置市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の眼科用医薬品・装置市場分析：米国、カナダ ・ヨーロッパの眼科用医薬品・装置市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの眼科用医薬品・装置市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の眼科用医薬品・装置市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの眼科用医薬品・装置市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck (US)、Pfizer (US)、Roche Holdings (Switzerland)、Santen Pharmaceutical(Japan)、Alcon (Switzerland)、Bausch & Lomb (US)、Carl Zeiss Meditec (Germany)、Essilor International S.A. (France)、Johnson & Johnson (US)、Nidek(Japan)、Topcon Corporation (Japan) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Ophthalmology is a branch of medicine that deals with the anatomy, physiology, and diseases of the eye.
Market Analysis and Insights: Global Opthalmology Drugs and Devices Market
The global Opthalmology Drugs and Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Opthalmology Drugs and Devices Scope and Market Size
Opthalmology Drugs and Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opthalmology Drugs and Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck (US)
Pfizer (US)
Roche Holdings (Switzerland)
Santen Pharmaceutical(Japan)
Alcon (Switzerland)
Bausch & Lomb (US)
Carl Zeiss Meditec (Germany)
Essilor International S.A. (France)
Johnson & Johnson (US)
Nidek(Japan)
Topcon Corporation (Japan)
Market segment by Type, the product can be split into
Device
Drug
Market segment by Application, split into
Hosptial
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opthalmology Drugs and Devices Revenue
1.4 Market by Type
1.4.1 Global Opthalmology Drugs and Devices Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Device
1.4.3 Drug
1.5 Market by Application
1.5.1 Global Opthalmology Drugs and Devices Market Share by Application: 2020 VS 2026
1.5.2 Hosptial
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Opthalmology Drugs and Devices Market Perspective (2015-2026)
2.2 Global Opthalmology Drugs and Devices Growth Trends by Regions
2.2.1 Opthalmology Drugs and Devices Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Opthalmology Drugs and Devices Historic Market Share by Regions (2015-2020)
2.2.3 Opthalmology Drugs and Devices Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Opthalmology Drugs and Devices Market Growth Strategy
2.3.6 Primary Interviews with Key Opthalmology Drugs and Devices Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Opthalmology Drugs and Devices Players by Market Size
3.1.1 Global Top Opthalmology Drugs and Devices Players by Revenue (2015-2020)
3.1.2 Global Opthalmology Drugs and Devices Revenue Market Share by Players (2015-2020)
3.1.3 Global Opthalmology Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Opthalmology Drugs and Devices Market Concentration Ratio
3.2.1 Global Opthalmology Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Opthalmology Drugs and Devices Revenue in 2019
3.3 Opthalmology Drugs and Devices Key Players Head office and Area Served
3.4 Key Players Opthalmology Drugs and Devices Product Solution and Service
3.5 Date of Enter into Opthalmology Drugs and Devices Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Opthalmology Drugs and Devices Historic Market Size by Type (2015-2020)
4.2 Global Opthalmology Drugs and Devices Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Opthalmology Drugs and Devices Market Size by Application (2015-2020)
5.2 Global Opthalmology Drugs and Devices Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Opthalmology Drugs and Devices Market Size (2015-2020)
6.2 Opthalmology Drugs and Devices Key Players in North America (2019-2020)
6.3 North America Opthalmology Drugs and Devices Market Size by Type (2015-2020)
6.4 North America Opthalmology Drugs and Devices Market Size by Application (2015-2020)
7 Europe
7.1 Europe Opthalmology Drugs and Devices Market Size (2015-2020)
7.2 Opthalmology Drugs and Devices Key Players in Europe (2019-2020)
7.3 Europe Opthalmology Drugs and Devices Market Size by Type (2015-2020)
7.4 Europe Opthalmology Drugs and Devices Market Size by Application (2015-2020)
8 China
8.1 China Opthalmology Drugs and Devices Market Size (2015-2020)
8.2 Opthalmology Drugs and Devices Key Players in China (2019-2020)
8.3 China Opthalmology Drugs and Devices Market Size by Type (2015-2020)
8.4 China Opthalmology Drugs and Devices Market Size by Application (2015-2020)
9 Japan
9.1 Japan Opthalmology Drugs and Devices Market Size (2015-2020)
9.2 Opthalmology Drugs and Devices Key Players in Japan (2019-2020)
9.3 Japan Opthalmology Drugs and Devices Market Size by Type (2015-2020)
9.4 Japan Opthalmology Drugs and Devices Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Opthalmology Drugs and Devices Market Size (2015-2020)
10.2 Opthalmology Drugs and Devices Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Opthalmology Drugs and Devices Market Size by Type (2015-2020)
10.4 Southeast Asia Opthalmology Drugs and Devices Market Size by Application (2015-2020)
11 India
11.1 India Opthalmology Drugs and Devices Market Size (2015-2020)
11.2 Opthalmology Drugs and Devices Key Players in India (2019-2020)
11.3 India Opthalmology Drugs and Devices Market Size by Type (2015-2020)
11.4 India Opthalmology Drugs and Devices Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Opthalmology Drugs and Devices Market Size (2015-2020)
12.2 Opthalmology Drugs and Devices Key Players in Central & South America (2019-2020)
12.3 Central & South America Opthalmology Drugs and Devices Market Size by Type (2015-2020)
12.4 Central & South America Opthalmology Drugs and Devices Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck (US)
13.1.1 Merck (US) Company Details
13.1.2 Merck (US) Business Overview
13.1.3 Merck (US) Opthalmology Drugs and Devices Introduction
13.1.4 Merck (US) Revenue in Opthalmology Drugs and Devices Business (2015-2020))
13.1.5 Merck (US) Recent Development
13.2 Pfizer (US)
13.2.1 Pfizer (US) Company Details
13.2.2 Pfizer (US) Business Overview
13.2.3 Pfizer (US) Opthalmology Drugs and Devices Introduction
13.2.4 Pfizer (US) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
13.2.5 Pfizer (US) Recent Development
13.3 Roche Holdings (Switzerland)
13.3.1 Roche Holdings (Switzerland) Company Details
13.3.2 Roche Holdings (Switzerland) Business Overview
13.3.3 Roche Holdings (Switzerland) Opthalmology Drugs and Devices Introduction
13.3.4 Roche Holdings (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
13.3.5 Roche Holdings (Switzerland) Recent Development
13.4 Santen Pharmaceutical(Japan)
13.4.1 Santen Pharmaceutical(Japan) Company Details
13.4.2 Santen Pharmaceutical(Japan) Business Overview
13.4.3 Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Introduction
13.4.4 Santen Pharmaceutical(Japan) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
13.4.5 Santen Pharmaceutical(Japan) Recent Development
13.5 Alcon (Switzerland)
13.5.1 Alcon (Switzerland) Company Details
13.5.2 Alcon (Switzerland) Business Overview
13.5.3 Alcon (Switzerland) Opthalmology Drugs and Devices Introduction
13.5.4 Alcon (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
13.5.5 Alcon (Switzerland) Recent Development
13.6 Bausch & Lomb (US)
13.6.1 Bausch & Lomb (US) Company Details
13.6.2 Bausch & Lomb (US) Business Overview
13.6.3 Bausch & Lomb (US) Opthalmology Drugs and Devices Introduction
13.6.4 Bausch & Lomb (US) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
13.6.5 Bausch & Lomb (US) Recent Development
13.7 Carl Zeiss Meditec (Germany)
13.7.1 Carl Zeiss Meditec (Germany) Company Details
13.7.2 Carl Zeiss Meditec (Germany) Business Overview
13.7.3 Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Introduction
13.7.4 Carl Zeiss Meditec (Germany) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
13.7.5 Carl Zeiss Meditec (Germany) Recent Development
13.8 Essilor International S.A. (France)
13.8.1 Essilor International S.A. (France) Company Details
13.8.2 Essilor International S.A. (France) Business Overview
13.8.3 Essilor International S.A. (France) Opthalmology Drugs and Devices Introduction
13.8.4 Essilor International S.A. (France) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
13.8.5 Essilor International S.A. (France) Recent Development
13.9 Johnson & Johnson (US)
13.9.1 Johnson & Johnson (US) Company Details
13.9.2 Johnson & Johnson (US) Business Overview
13.9.3 Johnson & Johnson (US) Opthalmology Drugs and Devices Introduction
13.9.4 Johnson & Johnson (US) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
13.9.5 Johnson & Johnson (US) Recent Development
13.10 Nidek(Japan)
13.10.1 Nidek(Japan) Company Details
13.10.2 Nidek(Japan) Business Overview
13.10.3 Nidek(Japan) Opthalmology Drugs and Devices Introduction
13.10.4 Nidek(Japan) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
13.10.5 Nidek(Japan) Recent Development
13.11 Topcon Corporation (Japan)
10.11.1 Topcon Corporation (Japan) Company Details
10.11.2 Topcon Corporation (Japan) Business Overview
10.11.3 Topcon Corporation (Japan) Opthalmology Drugs and Devices Introduction
10.11.4 Topcon Corporation (Japan) Revenue in Opthalmology Drugs and Devices Business (2015-2020)
10.11.5 Topcon Corporation (Japan) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Opthalmology Drugs and Devices Key Market Segments
Table 2. Key Players Covered: Ranking by Opthalmology Drugs and Devices Revenue
Table 3. Ranking of Global Top Opthalmology Drugs and Devices Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Opthalmology Drugs and Devices Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Device
Table 6. Key Players of Drug
Table 7. Global Opthalmology Drugs and Devices Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Opthalmology Drugs and Devices Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Opthalmology Drugs and Devices Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Opthalmology Drugs and Devices Market Share by Regions (2015-2020)
Table 11. Global Opthalmology Drugs and Devices Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Opthalmology Drugs and Devices Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Opthalmology Drugs and Devices Market Growth Strategy
Table 17. Main Points Interviewed from Key Opthalmology Drugs and Devices Players
Table 18. Global Opthalmology Drugs and Devices Revenue by Players (2015-2020) (Million US$)
Table 19. Global Opthalmology Drugs and Devices Market Share by Players (2015-2020)
Table 20. Global Top Opthalmology Drugs and Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opthalmology Drugs and Devices as of 2019)
Table 21. Global Opthalmology Drugs and Devices by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Opthalmology Drugs and Devices Product Solution and Service
Table 24. Date of Enter into Opthalmology Drugs and Devices Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Opthalmology Drugs and Devices Market Size by Type (2015-2020) (Million US$)
Table 27. Global Opthalmology Drugs and Devices Market Size Share by Type (2015-2020)
Table 28. Global Opthalmology Drugs and Devices Revenue Market Share by Type (2021-2026)
Table 29. Global Opthalmology Drugs and Devices Market Size Share by Application (2015-2020)
Table 30. Global Opthalmology Drugs and Devices Market Size by Application (2015-2020) (Million US$)
Table 31. Global Opthalmology Drugs and Devices Market Size Share by Application (2021-2026)
Table 32. North America Key Players Opthalmology Drugs and Devices Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Opthalmology Drugs and Devices Market Share (2019-2020)
Table 34. North America Opthalmology Drugs and Devices Market Size by Type (2015-2020) (Million US$)
Table 35. North America Opthalmology Drugs and Devices Market Share by Type (2015-2020)
Table 36. North America Opthalmology Drugs and Devices Market Size by Application (2015-2020) (Million US$)
Table 37. North America Opthalmology Drugs and Devices Market Share by Application (2015-2020)
Table 38. Europe Key Players Opthalmology Drugs and Devices Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Opthalmology Drugs and Devices Market Share (2019-2020)
Table 40. Europe Opthalmology Drugs and Devices Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Opthalmology Drugs and Devices Market Share by Type (2015-2020)
Table 42. Europe Opthalmology Drugs and Devices Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Opthalmology Drugs and Devices Market Share by Application (2015-2020)
Table 44. China Key Players Opthalmology Drugs and Devices Revenue (2019-2020) (Million US$)
Table 45. China Key Players Opthalmology Drugs and Devices Market Share (2019-2020)
Table 46. China Opthalmology Drugs and Devices Market Size by Type (2015-2020) (Million US$)
Table 47. China Opthalmology Drugs and Devices Market Share by Type (2015-2020)
Table 48. China Opthalmology Drugs and Devices Market Size by Application (2015-2020) (Million US$)
Table 49. China Opthalmology Drugs and Devices Market Share by Application (2015-2020)
Table 50. Japan Key Players Opthalmology Drugs and Devices Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Opthalmology Drugs and Devices Market Share (2019-2020)
Table 52. Japan Opthalmology Drugs and Devices Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Opthalmology Drugs and Devices Market Share by Type (2015-2020)
Table 54. Japan Opthalmology Drugs and Devices Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Opthalmology Drugs and Devices Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Opthalmology Drugs and Devices Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Opthalmology Drugs and Devices Market Share (2019-2020)
Table 58. Southeast Asia Opthalmology Drugs and Devices Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Opthalmology Drugs and Devices Market Share by Type (2015-2020)
Table 60. Southeast Asia Opthalmology Drugs and Devices Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Opthalmology Drugs and Devices Market Share by Application (2015-2020)
Table 62. India Key Players Opthalmology Drugs and Devices Revenue (2019-2020) (Million US$)
Table 63. India Key Players Opthalmology Drugs and Devices Market Share (2019-2020)
Table 64. India Opthalmology Drugs and Devices Market Size by Type (2015-2020) (Million US$)
Table 65. India Opthalmology Drugs and Devices Market Share by Type (2015-2020)
Table 66. India Opthalmology Drugs and Devices Market Size by Application (2015-2020) (Million US$)
Table 67. India Opthalmology Drugs and Devices Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Opthalmology Drugs and Devices Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Opthalmology Drugs and Devices Market Share (2019-2020)
Table 70. Central & South America Opthalmology Drugs and Devices Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Opthalmology Drugs and Devices Market Share by Type (2015-2020)
Table 72. Central & South America Opthalmology Drugs and Devices Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Opthalmology Drugs and Devices Market Share by Application (2015-2020)
Table 74. Merck (US) Company Details
Table 75. Merck (US) Business Overview
Table 76. Merck (US) Product
Table 77. Merck (US) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 78. Merck (US) Recent Development
Table 79. Pfizer (US) Company Details
Table 80. Pfizer (US) Business Overview
Table 81. Pfizer (US) Product
Table 82. Pfizer (US) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 83. Pfizer (US) Recent Development
Table 84. Roche Holdings (Switzerland) Company Details
Table 85. Roche Holdings (Switzerland) Business Overview
Table 86. Roche Holdings (Switzerland) Product
Table 87. Roche Holdings (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 88. Roche Holdings (Switzerland) Recent Development
Table 89. Santen Pharmaceutical(Japan) Company Details
Table 90. Santen Pharmaceutical(Japan) Business Overview
Table 91. Santen Pharmaceutical(Japan) Product
Table 92. Santen Pharmaceutical(Japan) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 93. Santen Pharmaceutical(Japan) Recent Development
Table 94. Alcon (Switzerland) Company Details
Table 95. Alcon (Switzerland) Business Overview
Table 96. Alcon (Switzerland) Product
Table 97. Alcon (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 98. Alcon (Switzerland) Recent Development
Table 99. Bausch & Lomb (US) Company Details
Table 100. Bausch & Lomb (US) Business Overview
Table 101. Bausch & Lomb (US) Product
Table 102. Bausch & Lomb (US) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 103. Bausch & Lomb (US) Recent Development
Table 104. Carl Zeiss Meditec (Germany) Company Details
Table 105. Carl Zeiss Meditec (Germany) Business Overview
Table 106. Carl Zeiss Meditec (Germany) Product
Table 107. Carl Zeiss Meditec (Germany) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 108. Carl Zeiss Meditec (Germany) Recent Development
Table 109. Essilor International S.A. (France) Business Overview
Table 110. Essilor International S.A. (France) Product
Table 111. Essilor International S.A. (France) Company Details
Table 112. Essilor International S.A. (France) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 113. Essilor International S.A. (France) Recent Development
Table 114. Johnson & Johnson (US) Company Details
Table 115. Johnson & Johnson (US) Business Overview
Table 116. Johnson & Johnson (US) Product
Table 117. Johnson & Johnson (US) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 118. Johnson & Johnson (US) Recent Development
Table 119. Nidek(Japan) Company Details
Table 120. Nidek(Japan) Business Overview
Table 121. Nidek(Japan) Product
Table 122. Nidek(Japan) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 123. Nidek(Japan) Recent Development
Table 124. Topcon Corporation (Japan) Company Details
Table 125. Topcon Corporation (Japan) Business Overview
Table 126. Topcon Corporation (Japan) Product
Table 127. Topcon Corporation (Japan) Revenue in Opthalmology Drugs and Devices Business (2015-2020) (Million US$)
Table 128. Topcon Corporation (Japan) Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opthalmology Drugs and Devices Market Share by Type: 2020 VS 2026
Figure 2. Device Features
Figure 3. Drug Features
Figure 4. Global Opthalmology Drugs and Devices Market Share by Application: 2020 VS 2026
Figure 5. Hosptial Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Opthalmology Drugs and Devices Report Years Considered
Figure 9. Global Opthalmology Drugs and Devices Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Opthalmology Drugs and Devices Market Share by Regions: 2020 VS 2026
Figure 11. Global Opthalmology Drugs and Devices Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Opthalmology Drugs and Devices Market Share by Players in 2019
Figure 14. Global Top Opthalmology Drugs and Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opthalmology Drugs and Devices as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Opthalmology Drugs and Devices Revenue in 2019
Figure 16. North America Opthalmology Drugs and Devices Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Opthalmology Drugs and Devices Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Opthalmology Drugs and Devices Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Opthalmology Drugs and Devices Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Opthalmology Drugs and Devices Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Opthalmology Drugs and Devices Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Opthalmology Drugs and Devices Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…- 糖尿病治療装置・薬剤の世界市場（～2026年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…
- 心臓手術・装置・薬剤の世界市場（～2026年） Cardiology is a branch of medicine dealing with disorders of the heart as well as parts of the circulatory system. One of the major factors driving the market is medical tourism. Market Analysis and Insights: Global Cardiology Surgery, Devices and Drugs Market The global Cardiology Surgery, Devices …
- 避妊薬・避妊具の世界市場（～2026年） A contraceptive is a device or drug that prevents a woman from becoming pregnant. The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population. Market Analysis and Insights: Gl…
- 神経インターベンショナルデバイスの世界市場（～2026年） As per the Society of Neurointerventional Surgery, neurointervention is an approach for treatment of conditions that occur within the vessels of the brain or within the spinal cavity. It is gaining high traction among neuro-specialists due to its minimally invasive technique and comparatively higher…